Chinese CRO Purchases Provantis SaaS to Increase Efficiencies, Further Enhance Quality and Automate Processes at R&D Facility in Nanjing.
Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Jiangsu Tripod Preclinical Research Laboratories Inc. (Tripod) has purchased the integrated Provantis preclinical software solution suite to automate processes at its Nanjing facility.
Founded in April 2008, Tripod is a nonclinical Contract Research Organization providing a wide range of high quality studies including Bioanalysis/DMPK/TK, general toxicity, safety pharmacology, reproductive toxicity, Geno toxicity, carcinogenicity studies and clinical pathology and histo-pathology tests.
Tripod’s investment in Provantis will deliver increased efficiencies in the collection, storage and reporting of key research data and will further improve service levels to sponsors.
Key Facts
- Tripod to implement Provantis 9, the latest version of Instem’s preclinical software solution suite
- Comprehensive suite of Provantis modules to be deployed including General Toxicology, Tables & Statistics, Protocol & Report Assembly, Dispense, Pathology, Clinical Pathology and Data Import
- Contract awarded following a detailed competitive evaluation; Provantis recognized as the overwhelming standard within China and the leading solution around the world
- Tripod to use the SaaS delivery model from Instem’s Shanghai-based data center, adding yet another laboratory to Instem’s established and rapidly growing hosting data center client roster
- A range of professional services purchased to facilitate quick implementation and a rapid return on investment
Neil Donaldson, VP Sales Europe & Asia, Instem, commented “Tripod is a well-established CRO with exciting growth plans and we are honored that they have chosen Instem and Provantis to help them further improve the level of service to their sponsors and support them in their objective of becoming a world-class non-clinical research organization.”
Instem’s Provantis solution was the first western toxicology/pathology software to enter into the Chinese market, deploying its initial system in one of the largest and most advanced vivariums during 2006. As the Chinese preclinical market continues to grow, Instem is leading the market with Instem solutions deployed at more sites within the region than any competing product.
Instem has an established full-service office in Shanghai and supports organizations serving the PRC through traditional on-site systems as well as through their SaaS delivery model from a secure, professionally managed data center based in Shanghai.
About Tripod
Located in Nanjing, the 2nd largest metropolitan in the Yangtse River Delta of China, Tripod takes great advantages of local industrial, cultural and educational resources. Strictly following OECD, FDA, SFDA,GLP regulations and AAALAC animal welfare requirements, Tripod is able to provide accurate, reliable and high quality nonclinical research services for global pharmaceutical companies, drug R&D enterprises and institutes. The core strength of Tripod is its intensively and extensively experienced professionals and management team. Tripod aims to become a world-class non-clinical contract research organization in the near future.
For further information about Tripod please visit http://www.tprglp.com/english/index.asp
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com
Meeting clients at the intersection of investment & return™.
http://www.linkedin.com/company/instem/
https://www.facebook.com/Instem.software
https://twitter.com/Instemsoftware
SOURCE: Instem
Press Contacts:
Instem
Julie Jones (UK HQ)
+44 (0) 1785 825600
julie.jones@instem.com
